Heart Failure POC & LOC Devices Market
Report ID: SQMIG35A3837
Report ID: SQMIG35A3837
[email protected]
USA +1 351-333-4748
Report ID:
SQMIG35A3837 |
Region:
Global |
Published Date: June, 2026
Pages:
157
|Tables:
116
|Figures:
72
Global Heart Failure Poc & Loc Devices Market size was valued at USD 2.52 Billion in 2024 and is poised to grow from USD 2.8 Billion in 2025 to USD 6.52 Billion by 2033, growing at a CAGR of 11.22% during the forecast period (2026-2033).
The primary driver of the heart failure point-of-care and lab-on-chip device market is the rising global burden of heart failure, which has compelled clinicians and health systems to seek rapid, decentralized diagnostic and monitoring solutions. This market encompasses portable immunoassays for BNP and NT-proBNP, microfluidic chips that perform multiplexed panels, wearable hemodynamic sensors and implantable pressure monitors, and its importance lies in enabling early detection, routine outpatient surveillance and reduction of avoidable hospital readmissions. Historically the field evolved from centralized laboratory assays toward bedside tests as miniaturization, biosensor sensitivity and data connectivity advanced, exemplified by POC BNP tests and CardioMEMS.
Building on the demonstrated clinical impact of devices such as CardioMEMS and bedside BNP assays, the dominant growth factor is the convergence of remote monitoring, data integration and value-based reimbursement that aligns incentives toward preventing readmissions. Because payers increasingly reward outcomes rather than procedures, health systems invest in POC and LOC technologies to gather continuous hemodynamic or biomarker data and trigger early interventions, lowering costs and justifying deployment. Hospitals use pulmonary artery pressure monitoring to reduce admissions, emergency departments deploy POC BNP to triage dyspnea faster and telehealth programs combine home tests with algorithms to personalize therapy, creating commercial opportunities.
How is AI improving diagnostics in the heart failure POC and LOC devices market?
AI is reshaping diagnostics in the heart failure point of care and lab on a chip market by turning complex physiological signals into clear clinical decisions. Key aspects include automated image analysis for cardiac and lung ultrasound, AI enhanced ECG interpretation and smart analytics for wearable and biosensor data that flag congestion and decompensation early. The current state moves capability out of specialist labs into primary care and emergency settings by reducing operator dependence and speeding triage. Market interest is driven by manufacturers and clinical groups seeking scalable screening pathways and earlier intervention. Notable implementations combine real time guidance, automated measurement and workflow integration to make bedside assessment more reliable.
Clarius June 2026, announced FDA clearance for an Ejection Fraction AI that automates left ventricular ejection fraction on handheld ultrasound. This innovation reduces subjectivity, shortens time to diagnosis and helps expand point of care screening so clinicians can refer and treat patients earlier, supporting market growth and efficiency.
Market snapshot - (2026-2033)
Global Market Size
USD 2.52 Billion
Largest Segment
Point-of-Care (POC) Diagnostic Devices
Fastest Growth
Lab-on-Chip (LOC) Devices
Growth Rate
11.22% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global heart failure poc & loc devices market is segmented by device type, biomarker tested, application, end-user and region. Based on device type, the market is segmented into Point-of-Care (POC) Diagnostic Devices and Lab-on-Chip (LOC) Devices. Based on biomarker tested, the market is segmented into BNP (B-type Natriuretic Peptide), Troponin and CRP. Based on application, the market is segmented into Diagnosis, Risk Stratification and Monitoring. Based on end-user, the market is segmented into Hospitals, Emergency Departments and Cardiology Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Point of care diagnostic devices segment dominates because these platforms align with clinician workflows that demand immediate, actionable results for acute decision making and care escalation. Their user friendly interfaces, established training pathways, and compatibility with existing hospital and emergency department protocols encourage widespread procurement. That clinical reliability and operational fit drive vendor focus on assay robustness and electronic integration, reinforcing their central position in heart failure testing and care pathways.
However, lab on chip devices are emerging as the fastest growing area, driven by microfluidic multiplexing that delivers multiple biomarker readouts from tiny samples. Advances in reagent stability and compact readers, together with demand for decentralized monitoring and integration into wearable and remote platforms, are catalyzing investment and new clinical use cases.
BNP segment dominates because its direct relationship with cardiac filling pressures and strong guideline support make it the principal diagnostic and monitoring biomarker for heart failure. Clinicians use BNP measurements to triage breathless patients and guide therapy adjustments, prompting device makers to prioritize BNP assay performance and workflow integration. This clinical centrality shapes reimbursement considerations and strategic partnerships that steer product development across the market.
However, troponin is emerging as the most rapidly expanding biomarker area, as high sensitivity assays and portable platforms broaden its role into heart failure risk stratification and myocardial injury surveillance. Innovations enabling earlier detection of cardiac injury, regulatory momentum for point of care use, and growing demand for prognostic multiparameter testing are accelerating adoption and creating new device opportunities.
To get detailed segments analysis, Request a Free Sample Report
North America dominance reflects a convergence of enabling factors that accelerate development, approval and adoption of heart failure point of care and lab on a chip devices. A dense ecosystem of device developers, clinical research institutions and specialized hospitals supports rapid iteration and evidence generation. Reimbursement environments and payer engagement favor technologies that demonstrate clinical utility and pathway integration, while regulatory agencies offer established frameworks that balance innovation with patient safety. Strong private investment and strategic partnerships with health systems facilitate scaling and distribution. Clinician familiarity with advanced diagnostics, established supply chains and a focus on outpatient and home based management further reinforce leadership. Cross sector collaboration among academia, industry and service providers sustains continuous product refinement and market maturation.
Heart Failure POC & LOC Devices Market in United States reflects a mature medtech environment where innovation is supported by extensive clinical infrastructure and active engagement from payers and providers. Hospitals and specialty clinics often serve as early adopters, enabling real world validation and iterative improvement. Established distribution networks and professional societies help integrate devices into care pathways, while venture funding and commercial partnerships drive commercialization and scale across diverse care settings.
Heart Failure POC & LOC Devices Market in Canada is shaped by a publicly financed healthcare framework that emphasizes value and equitable access. Provincial procurement mechanisms and collaborative health system pilots guide adoption, with strong interest in technologies that enable community based management and remote monitoring. Close collaboration between academic research centers and industry supports evidence generation, while attention to cost effectiveness and interoperability influences purchasing and deployment decisions.
Expansion across Europe is driven by harmonized clinical needs, policy support for decentralized care and an active innovation landscape that bridges medtech expertise and healthcare priorities. National health systems and regional purchasers are prioritizing solutions that reduce hospital burden and enable earlier intervention, creating demand for convenient diagnostics and monitoring platforms. Regulatory convergence and targeted reimbursement initiatives in key markets reduce barriers to cross border commercialization, while strong manufacturing capabilities and established clinical networks facilitate piloting and scale up. Collaboration between start ups, established medical device firms and academic centers contributes to a steady pipeline of clinically relevant offerings. Increasing clinician receptivity to integrated digital diagnostics and an emphasis on care pathway optimization further support rapid market expansion.
Heart Failure POC & LOC Devices Market in Germany benefits from a robust medical technology manufacturing base and well developed hospital infrastructure that supports clinical evaluation and incorporation of new diagnostics. Payer and hospital procurement focus on demonstrable clinical benefit and interoperability, while specialized cardiology centers and research institutions enable rigorous validation and adoption across acute and outpatient settings.
Heart Failure POC & LOC Devices Market in United Kingdom is characterized by accelerated adoption through health system innovation pathways and strong emphasis on digital transformation. Integrated care initiatives and regional innovation hubs support rapid piloting and deployment, while national guidance and procurement frameworks help translate clinical evidence into broader uptake. Collaboration between startups and health service organizations enhances practical implementation across community and secondary care.
Heart Failure POC & LOC Devices Market in France is emerging through focused public private initiatives and growing interest in home based care models. Regional hospital networks and community health programs are exploring diagnostic platforms that streamline patient management. Supportive policy signals and targeted pilot programs encourage manufacturers to demonstrate effectiveness within structured clinical environments and to align solutions with national health priorities.
Asia Pacific is strengthening its role through a combination of regulatory modernization, domestic manufacturing expansion and strategic collaborations with global medtech players. Governments and innovation agencies are facilitating pathways for clinical evaluation and market entry, while investments in digital health and telemedicine create demand for point of care diagnostics that can integrate into remote care models. Local device development is increasingly focused on cost effective, scalable platforms suited to diverse care settings, supported by strong electronics and life sciences capabilities. Cross border partnerships and clinical collaborations are accelerating knowledge transfer and product adaptation. Growing clinician experience with decentralized diagnostics and targeted policy support for chronic disease management further enhance market momentum across the region.
Heart Failure POC & LOC Devices Market in Japan reflects a sophisticated healthcare system with advanced hospital capabilities and high standards for clinical evidence. Domestic device developers and established medical firms work closely with specialist clinicians to refine device performance and usability. Emphasis on quality, integration with electronic medical records and alignment with national care pathways supports adoption in hospital and community settings.
Heart Failure POC & LOC Devices Market in South Korea is driven by a strong technology manufacturing ecosystem and rapid digital health uptake. Partnerships between electronics firms and medical device companies foster innovative sensor and connectivity solutions. Government supported innovation programs and hospital pilot initiatives promote real world testing and validation, enabling solutions that are readily integrated into telemedicine and community care models.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Prevalence Of Heart Failure
Technological Advancements In Diagnostics
Regulatory And Reimbursement Challenges
High Cost Of Development And Adoption
Request Free Customization of this report to help us to meet your business objectives.
Competitive dynamics in the global heart failure POC and LOC devices market center on incumbent consolidation, targeted partnerships, and rapid product differentiation. Major firms pursue acquisitions and distributor alliances such as Roche's purchase of LumiraDx cardiac assets and Quidel's combination with Ortho Clinical Diagnostics. Startups counter with microfluidic multiplex assays and AI-driven wearables exemplified by Omini's CardioCap and Cardiosense's CardioTag, intensifying platform and software competition.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global heart failure POC & LOC devices market is being driven by growing disease prevalence, with the key driver being rising heart failure rates that increase demand for rapid decentralized diagnostics and monitoring. A second driver is advancing technology, including microfluidics, wearable sensors and AI-enabled analytics that enable earlier intervention and remote care. A major restraint remains complex regulatory and reimbursement environments that can delay commercialization and limit adoption. North America is the dominating region due to mature clinical infrastructure, reimbursement pathways and strong industry-academic ecosystems, while the Point-of-Care Diagnostic Devices segment dominates because it delivers immediate, actionable results aligned with clinical workflows.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 2.52 Billion |
| Market size value in 2033 | USD 6.52 Billion |
| Growth Rate | 11.22% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Heart Failure POC & LOC Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Heart Failure POC & LOC Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Heart Failure POC & LOC Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Heart Failure POC & LOC Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Heart Failure Poc & Loc Devices Market size was valued at USD 2.52 Billion in 2024 and is poised to grow from USD 2.8 Billion in 2025 to USD 6.52 Billion by 2033, growing at a CAGR of 11.22% during the forecast period (2026-2033).
Competitive dynamics in the global heart failure POC and LOC devices market center on incumbent consolidation, targeted partnerships, and rapid product differentiation. Major firms pursue acquisitions and distributor alliances such as Roche's purchase of LumiraDx cardiac assets and Quidel's combination with Ortho Clinical Diagnostics. Startups counter with microfluidic multiplex assays and AI-driven wearables exemplified by Omini's CardioCap and Cardiosense's CardioTag, intensifying platform and software competition. 'Abbott Laboratories (i-STAT)', 'Roche Diagnostics (Cobas)', 'Siemens Healthineers', 'Quidel Corporation', 'bioMérieux SA', 'Beckman Coulter', 'Ortho Clinical Diagnostics', 'Alere (Abbott)', 'Chembio Diagnostics', 'Response Biomedical', 'Critical Diagnostics', 'Sphingotec GmbH', 'HyTest Ltd.', 'Nanosphere (Luminex)', 'Mindray Medical International'
The rising prevalence of heart failure increases clinical demand for accessible, rapid diagnostic and monitoring solutions at the point of care, encouraging manufacturers to prioritize development of portable and easy-to-use devices. Clinicians seek tools that enable earlier detection, frequent assessment, and outpatient management, which expands procurement by hospitals and clinics. Patient awareness and care pathways emphasizing early intervention further stimulate adoption, creating a feedback loop that supports investment, innovation, and broader distribution of POC and LOC technologies across care settings.
Connected Remote Monitoring: The market is shifting toward decentralized, in-home monitoring solutions that integrate wearable and implantable sensors with telehealth platforms. Stakeholders prioritize seamless interoperability and patient-centered designs that enable continuous symptom tracking, medication adherence support, and remote clinician engagement. Vendors emphasize ecosystems that combine device data, cloud analytics, and clinician dashboards to streamline care coordination. This trend supports earlier intervention, stronger patient engagement, and partnerships between device manufacturers, digital health providers, and care networks to scale longitudinal management outside hospital settings.
Region 1: Why does North America Dominate the Global Heart Failure POC & LOC Devices Market? |@12
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
